biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	AA8DF819-AF45-4E4C-B473-55A888333535
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-2Y-A9H4-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-2Y-A9H4-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-2Y-A9H4-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104736
biospecimen__bio__day_of_creation	12
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-2Y-A9H4.8A93B07B-8DCC-4DF4-B792-212C80E203FB.pdf
biospecimen__bio__plate_column	9
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	F
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-2Y-A9H4
biospecimen__shared__patient_id	A9H4
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	0DA00035-7ACE-443D-8ABE-E9CA6D0CD81F
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.6
clinical__chol_lihc_shared__albumin_result_upper_limit	5
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.3
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.2
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	7
clinical__chol_lihc_shared__fetoprotein_outcome_value	11
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	11.5
clinical__chol_lihc_shared__platelet_result_lower_limit	143
clinical__chol_lihc_shared__platelet_result_upper_limit	382
clinical__chol_lihc_shared__prothrombin_time_result_value	11
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	68
clinical__clin_shared__bcr_followup_barcode	TCGA-2Y-A9H4-F69087
clinical__clin_shared__bcr_followup_uuid	33D613BC-FC38-46C3-8CE3-3D4C67EDAF6E
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	12
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	223
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	HBV Surface Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2010
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	d5c5ae8e-9f61-4977-ba2e-df4d2486edc4
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-2Y-A9H4-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	005f5d46-7b08-480a-860e-2346d2fe892b
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	80ed52e2-925c-4f30-9fb9-e660295b2917
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	801b1d2c-eb6f-4eef-a00b-83da939d755a
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	b76fbb0a-cea0-5c73-acd8-77f71f3c8cdf
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	black or african american
gdc__demographic__year_of_birth	1942
gdc__diagnoses__age_at_diagnosis	25096
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-25096.0
gdc__diagnoses__days_to_last_follow_up	1452.0
gdc__diagnoses__diagnosis_id	0b934735-c994-5ec8-acf5-605884c92425
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	21.872422819032593
gdc__exposures__exposure_id	2fff64e8-79ac-5980-83b2-1417cf480140
gdc__exposures__height	167.0
gdc__exposures__weight	61.0
gdc__file_id	593d4a08-a05e-42c8-9440-4176fbf177fe
gdc__file_name	455502e4-9e9b-48b5-a6be-1a722de47909.mirbase21.mirnas.quantification.txt
gdc__file_size	50261
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	66e27e0fbbeb4fd0de482c0e1b7194d8
gdc__portions__is_ffpe	false
gdc__portions__portion_id	035d8d50-9ee2-4cf8-9263-14a5f8eacfa0
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1210
gdc__samples__initial_weight	100.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	8A93B07B-8DCC-4DF4-B792-212C80E203FB
gdc__samples__sample_id	c53e6fd9-76e1-44c3-af36-d1d0dfc2802a
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	2.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	7a83afc5-7433-42dc-bbe7-e7b9d0452ca8
gdc__submitter_id	mirna_swap_dr11_167_MirnaExpression871da248-9867-4ebe-bfae-232d68da40bb_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	2Y
gdc__tissue_source_site__name	Moffitt Cancer Center
gdc__tissue_source_site__tissue_source_site_id	33e340f9-a97a-56eb-a3e6-aad831681cb4
gdc__treatments__treatment_id	5c4fd3b0-bb1b-5bd3-a607-0586402bf814
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:25.101+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/d5c5ae8e-9f61-4977-ba2e-df4d2486edc4-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/d5c5ae8e-9f61-4977-ba2e-df4d2486edc4-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129632
manually_curated__local_md5	0b3ae265125f0ec2e73d15682558b03c
manually_curated__opengdc_download_date	2018-10-16T17:11:50.000795+02:00
manually_curated__opengdc_file_md5	df2f7f83327cf29c5bd5d48ee241ff5c
manually_curated__opengdc_file_size	50260
manually_curated__opengdc_id	d5c5ae8e-9f61-4977-ba2e-df4d2486edc4-meq
manually_curated__origin_file_size	129632
manually_curated__origin_last_modified_date	Tue Oct 16 17:30:00 CEST 2018
manually_curated__origin_md5	0b3ae265125f0ec2e73d15682558b03c
manually_curated__tissue_status	tumoral
